Chai Discovery triples to $3.8B in 7 months as OpenAI-backed drug designer lands $400M after Novartis deal
Chai Discovery has raised $400 million in a Series C round that values the AI drug discovery company…
Read the full articleYou might also wanna read
Chai brews up $400M series C to fuel AI molecule models used by Lilly, Novartis and Pfizer
Chai Discovery has continued its whirlwind emergence, closing its third financing round in 11 months to bring its total funding haul above $
AI Drug Discovery Startup Chai Discovery Attracts Pfizer, Eli Lilly; Seeks $400M at $3.4B Valuation
Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks to raise $400 m
forbes.com·1mo ago
Chai Discovery Announces $400M Series C to Advance AI-Driven Molecular Design
Chai Discovery, the company engineering AI models to discover new molecules led by Joshua Meier and Matthew McPartlon, has announced a $400M
OpenAI Researcher in Talks to Launch AI Drug Discovery Startup at $2B Valuation
Miles Wang, a researcher at OpenAI, is reportedly in discussions to launch a new startup focused on AI-driven drug discovery. The venture is
Ex-OpenAI Researcher Miles Wang Plans $2B AI Drug Discovery Startup
OpenAI researcher Miles Wang is leaving to start an AI drug discovery company, reportedly in talks to raise $200M at a $2B valuation led by
OpenAI Researcher Miles Wang Raises $200 Million for AI Drug Discovery Startup
OpenAI researcher Miles Wang is reportedly in talks to raise $200 million at a $2 billion valuation for a new AI drug discovery startup, wit
startupfortune.com·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.